Trial Profile

Dupilumab and Pregnancy Outcomes: A Retrospective Cohort Study Using Administrative Healthcare Databases (Dupi PODS)

Status: Not yet recruiting

Phase of Trial: Phase IV

Latest Information Update: 22 Feb 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Dupilumab (Primary)
Indications Atopic dermatitis
Focus Adverse reactions
Acronyms Dupi PODS
Sponsors Regeneron Pharmaceuticals

Most Recent Events

06 Nov 2019 Planned number of patients changed from 2833 to 3930.
06 Nov 2019 Planned End Date changed from 16 Jul 2026 to 21 Jul 2027.
06 Nov 2019 Planned primary completion date changed from 16 Jul 2026 to 21 Jul 2027.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com